tirzepatide autoinjector How the weight loss drug is also helping heart failure patients FDA Approves Lilly's Zepbound™ (tirzepatide)

Interesting to note is that a three-year study found tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity

This is a meaningful advantage over providers that ship monthly and occasionally leave customers waiting

Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis

At I40First in Amarillo, Texas, primary care providers Julito Uy, MD, George Peterson, DNP, FNP-C, AAHIVS, Susan Bailey, FNP-C, and the team offer safe and effective weight management options to teens and adults

Patients should be encouraged to monitor their own responses and discuss any concerns with their prescribing clinician or diabetes specialist nurse

We treat bioavailability as a non-negotiable standard